Harmony Biosciences Holdings, Inc. (HRMY)

Last Closing Price: 31.98 (2025-06-27)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Harmony Biosciences Holdings, Inc. (HRMY) had Net Income of $145.49M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$714.73M
Net Income
$145.49M
$156.81M
$557.92M
$523.91M
$190.83M
$0.98M
$191.80M
$191.80M
$145.49M
$145.49M
$145.49M
$145.49M
$190.83M
$213.38M
56.88M
57.87M
$2.56
$2.51
Balance Sheet Financials
$579.25M
$1.26M
$419.95M
$999.20M
$175.08M
$163.02M
$164.96M
$340.05M
$659.15M
$545.89M
$659.15M
57.15M
Cash Flow Statement Financials
$219.82M
$-67.48M
$-11.00M
$311.93M
$453.27M
$141.34M
$42.60M
--
--
Fundamental Metrics & Ratios
3.31
--
--
0.20
0.27
78.06%
26.70%
26.70%
29.85%
26.84%
20.36%
$218.67M
--
--
--
0.72
21.79
8.61
42.40
22.07%
26.65%
14.56%
17.70%
$11.53
$3.78
$3.80